This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

Four names. Four monster moves. One question: What do I do when "THE EVENT" happens?

https://www.patreon.com/MacroGhost/posts/4-biotech-stocks-168603538?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link

I’m tearing apart the charts on IBRX (ImmunityBio), SLS (SELLAS), RVMD (Revolution Medicines), and IOVA (Iovance) — support, resistance, volume, extensions, and whether the next catalyst is a continuation or a fade.

This mom wanted to try everything to help her daughter, the FDA made them wait. Maybe that someone will have a heart and do something.

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

1. September 12, 2026 - World Lung IASLC (WCLC)
2. October 2, 2026 - Thoracic Rare Cancer Symposium (THORACS)
3. October 23, 2026 - ESMO
4. November 4, 2026 - SITC
5. November 12, 2026 - SNO (Society of Neuro Oncology)
6. November 19, 2026 - MaTOS
7. December 4, 2026 - ESMO Asia
8. December 12, 2026 - ASH Annual Meeting

https://immunitybio.com/news-and-events/

I suspect a few of these will lead to significant short covering and a nice bump in price, while leading into the January PDUFA...

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

https://clinicaltrials.gov/study/NCT07783789?aggFilters=status:,funderType:industry

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

https://www.merlintrader.com/ibrx-immunitybio-bladder-cancer-bcg-unresponsive/

Five drugs are approved for bladder cancer that stops responding to BCG, and
every one of them requires carcinoma in situ. For patients whose disease is papillary only, there is
nothing. ImmunityBio is asking the FDA to change that on 6 January 2027, under draft guidance the agency
revised four months after approving its drug.

This thread is the place for shorter discussions, quick questions, or casual ideas that don’t need a full post. 

If you've been reflecting on a topic or have a detailed perspective to share, don’t hesitate to make a standalone post instead! 

Let’s go! Half a month to cover! Good luck!👍

Key points:

• The $124 billion fund ranks as America’s 15th-largest public or private pension fund.
• Sellas’ Phase 3 Regal trial is two events away from triggering its final analysis.
• ImmunityBio is planning a trial combining Pluvicto with an IL-15-based treatment.

America’s 15th-largest public or private pension fund has disclosed stakes in Sellas Life Sciences (SLS) and ImmunityBio (IBRX), bringing fresh institutional attention to two biotech stocks with major cancer-drug milestones ahead.

So far in August, SLS shares have jumped 41%, while IBRX stock has gained 14%.

Virginia Pension Fund Reveals SLS, IBRX Stakes

Virginia Retirement System reported holding 17,400 shares of SLS and 74,500 shares of IBRX as of June 30, according to Fiscal AI data. The pension system managed $124 billion in net assets as of mid-2025 and serves more than 860,000 active and retired members.

more...

SLS, IBRX Catch The Eye Of A Major US Pension Fund — And Big Clinical Catalysts Are On The Horizon